Abstract
Patients at high risk for the development of endometrial carcinoma are identified. The spectrum of endometrial cancer precursors is defined. Proof of adenomatous hyperplasia as a cancer precursor is offered. A therapeutic guide is proposed which considers the patient's age, her fertility status, the severity of her cancer precursor, or the virulence of her established cancer. By individualized planning, the patient can be treated optimally, receiving adequate therapy for cure and avoiding therapeutic penalties when unnecessary.
Original language | English |
---|---|
Pages (from-to) | 308-313 |
Number of pages | 6 |
Journal | Gynecologic Oncology |
Volume | 2 |
Issue number | 2-3 |
DOIs | |
State | Published - Aug 1974 |